Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Lyell Immunopharma, Inc. | StockGist | StockGist

Companies
LYEL
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings LYELSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Lyell Immunopharma, Inc.

Filed Nov 13, 2025

Accepted Nov 12, 2025, 7:00 PM ET

CIK 0001806952

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Lyell Immunopharma, Inc.

Person Type

OO

CUSIP: 55083R203

Amendment History

7 filings

SCHEDULE 13G
Original
Viewing
Nov 13, 20250001140361-25-042006
SCHEDULE 13G/A
Amendment 1
Feb 5, 20250002012383-25-001224
SCHEDULE 13G/A
Amendment 2
Feb 14, 20250001104659-25-013912
SCHEDULE 13G/A
Amendment 3
Feb 14, 20250001072613-25-000168
SCHEDULE 13G/A
Amendment 4
May 15, 20250001104659-25-049403
SCHEDULE 13G/A
Amendment 5
Nov 14, 20250001012975-25-000768
SCHEDULE 13G/A
Amendment 6
Latest
Nov 14, 20250001104659-25-112479

Recent Filings

Lyell Immunopharma, Inc.3 weeks ago

Lyell Immunopharma, Inc.3 weeks ago

Lyell Immunopharma, Inc.3 weeks ago

Lyell Immunopharma, Inc.3 months ago

Lyell Immunopharma, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice